BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2645218)

  • 1. A monoclonal antibody (BL2-10D1) reacting with a bladder-cancer-associated antigen.
    Longin A; Hijazi A; Berger-Dutrieux N; Escourrou G; Bouvier R; Richer G; Mironneau I; Fontanière B; Devonec M; Laurent JC
    Int J Cancer; 1989 Feb; 43(2):183-9. PubMed ID: 2645218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A useful monoclonal antibody (BL2-10D1) to identify tumor cells in urine cytology.
    Longin A; Fontaniere B; Berger-Dutrieux N; Devonec M; Laurent JC
    Cancer; 1990 Mar; 65(6):1412-7. PubMed ID: 2407335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of monoclonal antibody BL2-10D1 as a marker for the detection of the urothelial origin of tumors.
    Longin A; Berger-Dutrieux N; Fontaniere B; Cochran AJ; Devonec M; Dolbeau D; Guillaud M; Laurent JC
    Cancer; 1993 Nov; 72(9):2651-5. PubMed ID: 7691394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
    Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
    Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
    J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.
    Koho H; Paulie S; Ben-Aissa H; Jónsdóttir I; Hansson Y; Lundblad ML; Perlmann P
    Cancer Immunol Immunother; 1984; 17(3):165-72. PubMed ID: 6383600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a monoclonal antibody selective to human transitional cell carcinoma.
    Takahashi N; Koizumi Y; Kawaguchi T; Takahashi K; Suzuki T; Funyu T
    Tohoku J Exp Med; 1987 Feb; 151(2):213-20. PubMed ID: 3554615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis.
    Paulie S; Koho H; Ben-Aissa H; Hansson Y; Lundblad ML; Perlmann P
    Cancer Immunol Immunother; 1984; 17(3):173-9. PubMed ID: 6383601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells.
    Arndt R; Dürkopf H; Huland H; Donn F; Loening T; Kalthoff H
    J Urol; 1987 Apr; 137(4):758-63. PubMed ID: 3550155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
    Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
    J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H; Zhao Z; Sun H
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
    Kingsley EA; Carter TE; Barrow KD; Russell PJ
    Cancer Immunol Immunother; 1995 Dec; 41(6):348-54. PubMed ID: 8635192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
    Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
    Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivity of anti-human bladder cancer monoclonal antibodies with bladder tumor tissues].
    Kagawa S; Takigawa H; Kurokawa K; Masuko T; Hashimoto Y
    Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):133-9. PubMed ID: 3723905
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
    Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
    Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
    Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P
    Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.
    Fradet Y; Islam N; Boucher L; Parent-Vaugeois C; Tardif M
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7227-31. PubMed ID: 3313389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas.
    Fradet Y; LaRue H; Parent-Vaugeois C; Bergeron A; Dufour C; Boucher L; Bernier L
    Int J Cancer; 1990 Dec; 46(6):990-7. PubMed ID: 1701166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.